Lipoprotein lipase
Retatrutide, an investigational GIP, GLP-1, and GCG receptor agonist, holds promise for weight reduction in adults
Because research dosing is usually stepped up over time, a single 40mg pen does not last a fixed number of weeks it depends on the ramp
A normal BMI with metabolic issues would not qualify under the weight management pathway
TRIUMPH-4: Topline Data Highlights Retatrutide's Significant Weight Loss Effects On December 11, 2025, Eli Lilly announced positive topline results from the phase 3 TRIUMPH-4 trial, evaluating retatrutide in patients with specific metabolic comorbidities
Use Pain Relievers Safely An over-the-counter pain reliever may be appropriate for some people, but the safest choice depends on medical history and other medicines